Figure 4.

The amount of zein-mesalazine microparticles (mean ± SEM; n = 3) equivalent to a clinically used dose of mesalazine (250 mg) for samples prepared using various combinations of mesalazine (25–200 mg) and zein (200–800 mg). One-way factorial ANOVA with a post hoc Bonferroni test was used to compare selected means (varying quantities with constant ratio of zein and mesalazine, and a constant quantity of zein with varying mesalazine quantity). The means were not significantly different at p < 0.05.